Interview with Seroquel litigation attorney David Ennis: Part 2 "the evidence" and Study 15

In my previous post I interviewed Seroquel litigation attorney David Ennis, from the Ennis & Ennis lawfirm (see the interview here) in which he agreed to answer questions that I had emailed to him. His response to question 7 brought up the topic of lack of evidence to prove the connection of antipsychotic Seroquel to the diabetes injuries. I feel compelled to add to that here. I disagree, and wonder why the Judge did not consider internal documents that are, in my opinion damning evidence connecting Seroquel and diabetes. After all, it's on the box warning for Seroquel now.


Study 15 the buried study that changed lives

Washinton Post, 2009:

"It was a long-term trial of the antipsychotic drug Seroquel. The common wisdom in psychiatric circles was that newer drugs were far better than older drugs, but Study 15's results suggested otherwise.

As a result, newly unearthed documents show, Study 15 suffered the same fate as many industry-sponsored trials that yield data drugmakers don't like: It got buried. It took eight years before a taxpayer-funded study rediscovered what Study 15 had found -- and raised serious concerns about an entire new class of expensive drugs.

Study 15 was silenced in 1997, the same year Seroquel was approved by the Food and Drug Administration to treat schizophrenia. The drug went on to be prescribed to hundreds of thousands of patients around the world and has earned billions for London-based AstraZeneca International -- including nearly $12 billion in the past three years."-WaPo

From the AstraZeneca internal documents

HERE, it is clear that Seroquel was to be marketed per these 2001 documents directly to:

Target A u d i e n c es

• Global o p i n i on leaders (schizophrenia/bipolar)

* Prescribing psychiatrists/long t e rm care providers

• Patient Advocacy Gr o u ps (care-givers and patients)

* Global o p i n i on leaders (neurologists)

• Primary care physicians

With such obvious documentation of a planned marketing blitz for the antipsychotic Seroquel, along with the weight gain and diabetes information/data being hidden, buried or skewed, it--in my opinion--is cause for connection of the diabetes. The patients who were injured suffered a body organ damage, and they have not had their day in court to be heard properly.

AstraZeneca 'suppressed' drug test data

from BBC The marketing team sued over a drug's alleged side effects tried to suppress key data, an ex-employee has claimed-January 2010:

"Seroquel's former UK medical adviser told the BBC he was pressured to approve promotional material which said weight gain was not an issue.

Maker AstraZeneca, which faces fresh legal action next month, said it took concerns about its conduct seriously.

In the same programme, the British Medical Journal editor urged that the medicine licensing system be reviewed.

Dr Fiona Godlee said industry should no longer provide the evaluations of its own drugs which the licensing body considered.

'Job threat'
Thousands of patients are suing AstraZeneca in US courts, claiming the anti-psychotic drug Seroquel caused weight gain and diabetes."

Listen to the former AstraZeneca medical advisor's gripping audio tape in that BBC article link.

AstraZeneca spent over $700 million dollars in legal defense and may not have to end up paying the lawsuit victims, so in the end who wins? when Big Pharma loses they win, the injured client remains with a body organ that doesn't work --diabetes is a killer--and a shortened lifespan.

Business as usual?